1498 — PuraPharm Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual balance sheet for PuraPharm, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	59.7	75.8	20.1	12.8	16.2
Net Total Accounts Receivable
Net Total Receivables	300	156	113	88.7	56.4
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	611	486	350	268	227
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	492	431	397	355	353
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,206	1,016	844	716	694
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	665	665	571	491	479
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	804	758	691	605	563
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	402	258	153	111	130
Total Liabilities & Shareholders' Equity	1,206	1,016	844	716	694
Total Common Shares Outstanding